Today: 23 April 2026
Subscribe
Browse Category

Stock Market 9 December 2025

PepsiCo Stock Today: Elliott Deal, 2026 Outlook and Analyst Targets for PEP (December 9, 2025)

PepsiCo Stock Today: Elliott Deal, 2026 Outlook and Analyst Targets for PEP (December 9, 2025)

PepsiCo shares traded near $145.34 on December 9, 2025, after announcing a major cost-cutting and product simplification plan tied to a deal with Elliott Investment Management, which holds a $4 billion stake. The company will cut about 20% of U.S. product lines and introduce lower prices. Analysts raised price targets but remain cautious on near-term growth. Year-to-date, PepsiCo stock is down about 4%, trailing the S&P 500.
9 December 2025
·
Ares Management (ARES) Soars on S&P 500 Inclusion: Latest News, Analyst Forecasts and What’s Next for the Stock

Ares Management (ARES) Soars on S&P 500 Inclusion: Latest News, Analyst Forecasts and What’s Next for the Stock

Ares Management shares jumped as much as 11% intraday on December 9, 2025, after news it will join the S&P 500, replacing Kellanova, which is being acquired by Mars. ARES traded in the mid-$170s, up roughly 6–10% on the day. S&P Dow Jones Indices said the change takes effect before the market opens December 11. Index funds tracking the S&P 500 will buy Ares and sell Kellanova.
9 December 2025
··
IMAX Stock Soars on Analyst Upgrades and China Growth: What December 2025’s Rally Really Means

IMAX Stock Soars on Analyst Upgrades and China Growth: What December 2025’s Rally Really Means

IMAX shares closed at $38.50 on December 8, up 7.8% after new analyst upgrades and news of a deepened China partnership. The stock sits near a 52-week high, up over 30% in six months, outpacing the broader market. Consensus analyst price targets now range from $32 to $47, with most ratings at “Buy.” Management issued bullish three-year growth guidance at its recent Investor Day.
9 December 2025
··
Top US Stock Market Losers Today (December 9, 2025): HURA, Phreesia, Virgin Galactic, SLM, Gogo and More

Top US Stock Market Losers Today (December 9, 2025): HURA, Phreesia, Virgin Galactic, SLM, Gogo and More

TuHURA Biosciences plunged 36.9% after announcing a $15.6 million direct offering with warrants, triggering heavy dilution concerns. Phreesia, Euda Health, SLM Corp, Virgin Galactic, and Gogo each fell more than 15%. Major indexes stayed mostly flat, with the Dow up 0.2% and the S&P 500 up 0.1% as traders awaited the Federal Reserve’s policy decision.
9 December 2025
··········
Top Gainers on the US Stock Market Today (December 9, 2025): AFJK, NCPL, XCUR, ALEX and More Surge as Fed Meeting Looms

Top Gainers on the US Stock Market Today (December 9, 2025): AFJK, NCPL, XCUR, ALEX and More Surge as Fed Meeting Looms

Small- and mid-cap US stocks surged Tuesday, with Aimei Health Technology jumping 180% and Netcapital up 134%, driven by deal and biotech news. Major indexes were muted ahead of the Federal Reserve’s interest-rate decision; the Dow edged higher, the S&P 500 was flat, and the Nasdaq slipped. Traders focused on Fed Chair Jerome Powell’s upcoming press conference and expectations of a rate cut.
9 December 2025
·
Canada Stock Market Today, December 9, 2025: TSX Climbs as Gold Stocks Rally Ahead of Fed and Bank of Canada Decisions

Canada Stock Market Today, December 9, 2025: TSX Climbs as Gold Stocks Rally Ahead of Fed and Bank of Canada Decisions

Toronto’s S&P/TSX Composite Index closed up 0.5% at 31,328.16 on Tuesday, led by gains in gold miners, utilities, and major financials. The benchmark hovered near its all-time high as investors awaited interest-rate decisions from the U.S. Federal Reserve and Bank of Canada. Trading volume topped 37 million shares. Gold-mining stocks and TransAlta posted strong advances.
9 December 2025
······
Arrowhead Pharmaceuticals (ARWR) Stock Soars on First FDA Approval, Novartis Deal and New Alzheimer’s Trial

Arrowhead Pharmaceuticals (ARWR) Stock Soars on First FDA Approval, Novartis Deal and New Alzheimer’s Trial

Arrowhead Pharmaceuticals stock surged to a 52-week high of $71.5 on December 8, 2025, after securing its first FDA approval for REDEMPLO and announcing a major Novartis licensing deal. Shares traded around $69 on December 9, up over 260% year-to-date, with market value near $9.5 billion. Trading volume more than doubled typical levels. The company also began dosing in an Alzheimer’s trial.
9 December 2025
··
Robinhood (HOOD) Stock Today: Price, Latest News, Crypto Expansion and 2026 Forecasts

Robinhood (HOOD) Stock Today: Price, Latest News, Crypto Expansion and 2026 Forecasts

Robinhood Markets traded near $136 per share on December 9, 2025, with a market cap around $122 billion and a P/E ratio near 57. The stock has surged over 240% year-to-date, leading the S&P 500. Early December saw Robinhood launch crypto staking and new trading features in the U.S. and Europe. Wall Street forecasts now show mixed expectations after the sharp rally.
9 December 2025
··
Carvana Stock (CVNA) Soars on S&P 500 Inclusion: Latest Price, News, Analyst Forecasts and Risks as of December 9, 2025

Carvana Stock (CVNA) Soars on S&P 500 Inclusion: Latest Price, News, Analyst Forecasts and Risks as of December 9, 2025

Carvana shares traded near $450 on December 9, 2025, after S&P Dow Jones Indices announced the company will join the S&P 500 on December 22. The stock has surged about 120% in 2025 and over 8,000% since late 2022, pushing Carvana’s market value above Ford and GM. Recent earnings showed record Q3 results and strong guidance for Q4.
9 December 2025
··
Warby Parker (WRBY) Soars on Google AI Glasses News: Is the Stock a Buy After December 2025’s Rally?

Warby Parker (WRBY) Soars on Google AI Glasses News: Is the Stock a Buy After December 2025’s Rally?

Warby Parker shares jumped over 13% to around $22 after Google confirmed their co-developed AI smart glasses will launch in 2026. The announcement, made at The Android Show, marks the first public timeline for the product. Google has committed up to $150 million to the partnership. Shares of rival EssilorLuxottica fell 4% as investors reacted to the news.
9 December 2025
···
Confluent (CFLT) Stock Surges on IBM’s $11 Billion Takeover – What the $31 Cash Offer Means for Investors on December 9, 2025

Confluent (CFLT) Stock Surges on IBM’s $11 Billion Takeover – What the $31 Cash Offer Means for Investors on December 9, 2025

IBM will acquire Confluent for $31 per share in cash, valuing the deal at about $11 billion, a 34–35% premium to pre-deal prices. Confluent stock is trading near $29.87, with a 3–4% spread to the offer. Several banks downgraded Confluent to Hold/Neutral after the announcement. Shareholder law firms have launched investigations into whether the $31 offer is adequate.
9 December 2025
···
Warner Bros. Discovery (WBD) Stock Today: Paramount’s $108 Billion Hostile Bid, Netflix Deal Risk and 2026–2050 Forecasts

Warner Bros. Discovery (WBD) Stock Today: Paramount’s $108 Billion Hostile Bid, Netflix Deal Risk and 2026–2050 Forecasts

Paramount Skydance launched a $108.4 billion hostile all-cash tender offer for Warner Bros. Discovery at $30 per share, challenging Netflix’s $72 billion deal for WBD’s studios and streaming assets. WBD’s board acknowledged the Paramount bid but continues to back the Netflix agreement, asking shareholders to wait for a formal recommendation. WBD stock traded near $27, close to its 52-week high. Wall Street’s 12-month target is $22.35.
9 December 2025
···
Micron (MU) Stock Today: HSBC’s New $330 Target, AI Memory Supercycle and What Comes Next After a 170%+ Rally

Micron (MU) Stock Today: HSBC’s New $330 Target, AI Memory Supercycle and What Comes Next After a 170%+ Rally

HSBC initiated coverage of Micron Technology on December 9 with a “Buy” rating and a $330 price target, projecting 30–35% upside. Micron closed at $246.92 on December 8, up 4.1% for the day, after reporting record fiscal 2025 results and a year-to-date gain of about 170–180%. The company is shifting focus to high-bandwidth memory and data-center DRAM, exiting its consumer Crucial brand.
9 December 2025
··
Therapeutics (KYMR) Stock Rockets on KT‑621 Eczema Breakthrough, Then Pauses After $500M Share Offering – 9 December 2025 Update

Therapeutics (KYMR) Stock Rockets on KT‑621 Eczema Breakthrough, Then Pauses After $500M Share Offering – 9 December 2025 Update

Kymera Therapeutics shares jumped 41.6% to close at $94.30 on December 8 after its oral STAT6 degrader KT-621 showed dupilumab-like efficacy and clean safety in a small Phase 1b eczema trial. The company announced a $500 million stock offering the same day, sending shares lower in after-hours trading. Analyst price targets rose, some reaching $138.
9 December 2025
····
Oracle Stock (ORCL) Today: AI Backlog, Debt Jitters and Q2 FY 2026 Earnings Preview for December 9, 2025

Oracle Stock (ORCL) Today: AI Backlog, Debt Jitters and Q2 FY 2026 Earnings Preview for December 9, 2025

Oracle shares traded near $221 midday Monday, down about 36% from September’s record high after a surge driven by AI cloud deals. Q2 fiscal 2026 earnings are due after the close December 10, with Wall Street expecting $16.2 billion in revenue and $1.64 adjusted EPS. Options markets are pricing a roughly 11% swing on the results. The stock’s slide follows concerns over rising debt and heavy AI infrastructure spending.
9 December 2025
··
B2Gold Corp (BTG) Stock Update for December 9, 2025: Goose Mine Milestone, Q3 Beat and Analyst Price Targets

B2Gold Corp (BTG) Stock Update for December 9, 2025: Goose Mine Milestone, Q3 Beat and Analyst Price Targets

B2Gold Corp reported Q3 2025 gold revenue of $782.9 million, up 75% year-over-year, after achieving commercial production at its Goose Mine in Nunavut. Shares traded near $4.48 midday Dec. 9, valuing the company at $6.1 billion. Net income reached $19–23 million, reversing a loss last year. Gold output totaled 254,369 ounces, with costs and production beating targets.
9 December 2025
····
1 … 1,031 1,032 1,033 1,034 1,035 … 1,384

Stock Market Today

  • American Woman Shares Confusion Over Australian Petrol Stations
    April 23, 2026, 10:59 AM EDT. American woman Tate Duane highlighted differences in fueling practices between the U.S. and Australia. In Australia, petrol pumps lack the automatic click-off mechanism common in the U.S., requiring drivers to hold the fuel pump handle manually during refueling for safety reasons. Payment also differs; Australians typically prepay inside the station using their vehicle's number plate number as identification, unlike U.S. pumps with contactless payment on the spot. Many Australian stations close overnight, leading to questions about late-night fueling. Locals in TikTok comments explained these differences arose from safety concerns and local regulations, emphasizing surveillance and legal consequences to prevent drive-offs without payment. The video underscores cultural distinctions in everyday logistics such as vehicle fueling between countries.

Latest article

Google Stock Gets Fresh AI Catalyst as Alphabet Unveils Agents, Chips Before Earnings

Google Stock Gets Fresh AI Catalyst as Alphabet Unveils Agents, Chips Before Earnings

23 April 2026
Alphabet Class A shares traded near $340 Thursday morning, valuing the company at about $4.1 trillion after Google unveiled new enterprise AI software and custom chips at its Cloud Next event. The announcements come days before Alphabet reports first-quarter earnings on April 29, with investors watching for signs that heavy AI and cloud spending will drive revenue growth.
FirstEnergy Ohio Rate Plan Could Add $4-$5 a Month to Bills as May 22 Filing Nears

FirstEnergy Ohio Rate Plan Could Add $4-$5 a Month to Bills as May 22 Filing Nears

23 April 2026
FirstEnergy’s Ohio utilities will file a three-year rate plan with state regulators by May 22, seeking to fund $800 million annually in grid upgrades and $83 million for tree trimming. The plan would raise monthly bills for typical 1,000-kWh households by $4.26 to $5.30 if approved. The filing follows recent rate cases by AES Ohio and AEP Ohio under the new House Bill 15 regime.
Go toTop